Birdwatch Note Rating
2024-11-28 22:22:59 UTC - NOT_HELPFUL
Rated by Participant: 77D975F8610C5DE77517CAF77A3A6A055F28549F5B8827510E4FA5FCE8192714
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details